<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> (MetS) represents a combination of cardiometabolic risk factors, including visceral <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, elevated <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, reduced <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>MetS is rapidly increasing in prevalence worldwide as a consequence of the "epidemic" <z:hpo ids='HP_0001513'>obesity</z:hpo>, with a considerable impact on the global incidence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>At present, there is a growing interest on the role of visceral fat accumulation in the occurrence of MetS </plain></SENT>
<SENT sid="3" pm="."><plain>In this review, the effects of adipocytokines and other proinflammatory factors produced by fat accumulation on the occurrence of the MetS have been also emphasized </plain></SENT>
<SENT sid="4" pm="."><plain>Accordingly, the "hypoadiponectinemia" has been proposed as the most interesting new hypothesis to explain the pathophysiology of MetS </plain></SENT>
</text></document>